epirubicin has been researched along with Cirrhoses, Experimental Liver in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Y; Huang, X; Liu, C; Qu, K; Qu, P; Wu, Y; Xing, J; Xu, X; Yan, Z; Yuan, P; Zhang, H; Zhang, J | 1 |
1 other study(ies) available for epirubicin and Cirrhoses, Experimental Liver
| Article | Year |
|---|---|
Transarterial chemoembolization aggravated peritumoral fibrosis via hypoxia-inducible factor-1α dependent pathway in hepatocellular carcinoma.
Topics: Adult; Aged; Animals; Carcinoma, Hepatocellular; Cell Hypoxia; Chemoembolization, Therapeutic; Disease Models, Animal; Disease Progression; Epirubicin; Female; Fibrosis; Fluorouracil; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Infusions, Intra-Arterial; Liver; Liver Cirrhosis, Experimental; Liver Neoplasms; Male; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Rats, Sprague-Dawley | 2015 |